Functional dyspepsia. Functional dyspepsia
Conditions
Interventions
Intervention 1: Intervention group: Intervention group: GHors-Golmohammadi tablet consisting of R. damascena petals and dried licorice and N. jatamansi rhizomes, with a dose of 500 mg, three times a d
Sponsors
Babol University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to 65 Years
Inclusion criteria
Inclusion criteria: Patients with complaints of Functional dyspepsia Diagnosis of functional dyspepsia based on ROME IV criteria by gastroenterologist Helicobacter pylori infection positive test
Exclusion criteria
Exclusion criteria: History of peptic ulcer or reflux disease Endoscopy with specific pathological findings The presence of underlying diseases including heart failure, high blood pressure, kidney failure and uremic disease, cirrhosis History of abdominal surgery Any type of malignancy, history of chemotherapy and radiotherapy or exposure to radioactive radiation Pregnancy and breastfeeding Helicobacter pylori infection negative test NSAIDs or any herbal medicine use Smoking and alcohol consumption History of any sensitivity to formulation components
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The effect of «Ghors-Gol-mohammadi» on the severity of Functiona dyspepsia symptoms based on the total score of the GSRS questionnaire. Timepoint: At the beginning of the study, the second, fourth, sixth and eighth weeks from the beginning of the intervention. Method of measurement: Gastrointestinal Symptom Rating Scale questionnaire. | — |
Secondary
| Measure | Time frame |
|---|---|
| The effect of "Ghors-Gol-mohammadi" on the severity of gastrointestinal symptoms in each of the 5 subgroups of symptoms of the Gastrointestinal Symptom Rating Scale questionnaire and the symptoms related to postprandial distress syndrome. Timepoint: Before starting the intervention, the second, fourth, and eighth following weeks. Method of measurement: Gastrointestinal Symptom Rating Scale.;Score of quality of life. Timepoint: before the starting the intervention and at the eighth week. Method of measurement: Persian Nepean Quality of Life Questionnaire (NDI-10).;Helicobacter pylori infection. Timepoint: Before the starting of the study and at the sixth week. Method of measurement: Urea breath test. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactNader Behgam
Babol University of Medical Sciences
Outcome results
None listed